X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
33
PharmaCompass offers a list of Glimepiride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Glimepiride manufacturer or Glimepiride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Glimepiride manufacturer or Glimepiride supplier.
PharmaCompass also assists you with knowing the Glimepiride API Price utilized in the formulation of products. Glimepiride API Price is not always fixed or binding as the Glimepiride Price is obtained through a variety of data sources. The Glimepiride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Glimepiride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Glimepiride, including repackagers and relabelers. The FDA regulates Glimepiride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Glimepiride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Glimepiride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Glimepiride supplier is an individual or a company that provides Glimepiride active pharmaceutical ingredient (API) or Glimepiride finished formulations upon request. The Glimepiride suppliers may include Glimepiride API manufacturers, exporters, distributors and traders.
click here to find a list of Glimepiride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Glimepiride DMF (Drug Master File) is a document detailing the whole manufacturing process of Glimepiride active pharmaceutical ingredient (API) in detail. Different forms of Glimepiride DMFs exist exist since differing nations have different regulations, such as Glimepiride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Glimepiride DMF submitted to regulatory agencies in the US is known as a USDMF. Glimepiride USDMF includes data on Glimepiride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Glimepiride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Glimepiride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Glimepiride Drug Master File in Japan (Glimepiride JDMF) empowers Glimepiride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Glimepiride JDMF during the approval evaluation for pharmaceutical products. At the time of Glimepiride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Glimepiride suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Glimepiride Drug Master File in Korea (Glimepiride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Glimepiride. The MFDS reviews the Glimepiride KDMF as part of the drug registration process and uses the information provided in the Glimepiride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Glimepiride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Glimepiride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Glimepiride suppliers with KDMF on PharmaCompass.
A Glimepiride CEP of the European Pharmacopoeia monograph is often referred to as a Glimepiride Certificate of Suitability (COS). The purpose of a Glimepiride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Glimepiride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Glimepiride to their clients by showing that a Glimepiride CEP has been issued for it. The manufacturer submits a Glimepiride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Glimepiride CEP holder for the record. Additionally, the data presented in the Glimepiride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Glimepiride DMF.
A Glimepiride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Glimepiride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Glimepiride suppliers with CEP (COS) on PharmaCompass.
A Glimepiride written confirmation (Glimepiride WC) is an official document issued by a regulatory agency to a Glimepiride manufacturer, verifying that the manufacturing facility of a Glimepiride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Glimepiride APIs or Glimepiride finished pharmaceutical products to another nation, regulatory agencies frequently require a Glimepiride WC (written confirmation) as part of the regulatory process.
click here to find a list of Glimepiride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Glimepiride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Glimepiride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Glimepiride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Glimepiride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Glimepiride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Glimepiride suppliers with NDC on PharmaCompass.
Glimepiride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Glimepiride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Glimepiride GMP manufacturer or Glimepiride GMP API supplier for your needs.
A Glimepiride CoA (Certificate of Analysis) is a formal document that attests to Glimepiride's compliance with Glimepiride specifications and serves as a tool for batch-level quality control.
Glimepiride CoA mostly includes findings from lab analyses of a specific batch. For each Glimepiride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Glimepiride may be tested according to a variety of international standards, such as European Pharmacopoeia (Glimepiride EP), Glimepiride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Glimepiride USP).
Market Place
